Pregled po CROSBI profilu: Marko Lucijanic (CROSBI Profil: 34517, MBZ: 365834, ORCID: 0000-0002-1372-2040, OBAD: -347024)
Pronađeno 185 radova
-
101.Colchicine in Patients with Chronic Coronary Disease // The New England journal of medicine, 384 (2021), 8; 777-778 doi:10.1056/NEJMc2034992 (međunarodna recenzija, članak, znanstveni)
-
102.Pharmacist-led interventions might improve quality of life among older adult patients receiving warfarin treatment in rural areas: results from a randomized controlled trial // Research square, 11 (2020), 13773, 13 doi:10.1038/s41598-021-01394-0 (međunarodna recenzija, članak, znanstveni)
-
103.The Effect of Smoking on Disease Activity in Rheumatoid Arthritis – Our Experience // Acta clinica Croatica, 59 (2020), 2; 312-317 doi:10.20471/acc.2020.59.02.15 (međunarodna recenzija, članak, znanstveni)
-
104.Correlation between the level of colorectal anastomosis and anorectal function // Acta clinica Croatica, 59 (2020), 4; 703-711 doi:10.20471/acc.2020.59.04.17 (međunarodna recenzija, članak, znanstveni)
-
105.Progressive multifocal leukoencephalopathy during rituximab maintenance after rituximab and bendamustine treatment for relapsed follicular lymphoma // Annals of Hematology, 99 (2020), 9; 2191-2192 doi:10.1007/s00277-020-04143-x (međunarodna recenzija, pismo uredniku, znanstveni)
-
106.Patterns of anticoagulation therapy in atrial fibrillation: results from a large real-life single-center registry // Croatian Medical Journal, 61 (2020), 5; 440-449 doi:10.3325/cmj.2020.61.440 (međunarodna recenzija, članak, znanstveni)
-
107.Azacitidine and Venetoclax in AML // The New England journal of medicine, 383 (2020), 21; 2087-2089 doi:10.1056/NEJMc2029153 (međunarodna recenzija, pismo uredniku, znanstveni)
-
108.Yoga leads to sustained improvement in fatigue and mood in rheumatoid arthritis: preliminary results of a randomized controlled trial // Annals of the Rheumatic Diseases, Vol. 79, Suppl. 1 (2020)
London : Delhi: BMJ, 2020. str. 528-528 doi:10.1136/annrheumdis-2020-eular.1876 (poster, međunarodna recenzija, sažetak, znanstveni) -
109.Neutral effect of Glioma-associated oncogene-1 expression on survival in myelofibrosis // Wiener klinische Wochenschrift, 15 (2020), 464-466 (međunarodna recenzija, članak, znanstveni)
-
110.Higher AURKA and PLK1 expression are associated with inferior overall survival in patients with myelofibrosis // Blood Cells, Molecules, and Diseases, 81 (2020), 102396; 1-5 doi:10.1016/j.bcmd.2019.102396 (međunarodna recenzija, članak, znanstveni)
-
111.C reactive protein to albumin ratio as prognostic marker in primary and secondary myelofibrosis // Leukemia & lymphoma, 61 (2020), 12; 2969-2974 doi:10.1080/10428194.2020.1789627 (međunarodna recenzija, članak, znanstveni)
-
112.Ruxolitinib treatment improves muscle mass in patients with myelofibrosis // Annals of Hematology, 100 (2020), 4; 1105-1106 doi:10.1007/s00277-020-04243-8 (međunarodna recenzija, pismo uredniku, znanstveni)
-
113.CDC25c expression in patients with myelofibrosis is associated with stronger myeloproliferation and shorter overall survival // Wiener klinische Wochenschrift, 134 (2020), 1-2; 83-85 doi:10.1007/s00508-020-01738-2 (međunarodna recenzija, kratko priopcenje, znanstveni)
-
114.Effect of age and comorbidities on the decline of glomerular filtration rate in chronic myeloid leukemia patients discontinuing tyrosine kinase inhibitors // International Journal of Hematology, 112 (2020), 2; 264-264 doi:10.1007/s12185-020-02915-9 (međunarodna recenzija, komentar, znanstveni)
-
115.Hyperuricemia might promote thrombosis in essential thrombocythemia and polycythemia vera // Leukemia & Lymphoma, 61 (2020), 7; 1744-1747 doi:10.1080/10428194.2020.1731503 (međunarodna recenzija, pismo uredniku, znanstveni)
-
116.A validation of the Croatian version of Zarit Burden Interview and clinical predictors of caregiver burden in informal caregivers of patients with dementia: a cross-sectional study // Croatian Medical Journal, 61 (2020), 6; 527-537 doi:10.3325/cmj.2020.61.527 (međunarodna recenzija, članak, znanstveni)
-
117.C reactive protein to albumin ratio as prognostic marker in primary and secondary myelofibrosis // Leukemia & lymphoma, 61 (2020), 12; 2969-2974 (međunarodna recenzija, članak, znanstveni)
-
118.Reduced renal function strongly affects survival and thrombosis in patients with myelofibrosis // Annals of hematology, 100 (2020), 32862283, 7 doi:10.1007/s00277-020-04239-4 (međunarodna recenzija, članak, znanstveni)
-
119.Comment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912–1920 // Diabetes Care, 43 (2020), 2; e28-e29 doi:10.2337/dc19-2039 (međunarodna recenzija, pismo uredniku, znanstveni)
-
120.On interactions between body mass index, type of anticoagulation and outcomes // International Journal of Cardiology, 312 (2020), 107-107 doi:10.1016/j.ijcard.2020.04.064 (međunarodna recenzija, pismo uredniku, znanstveni)
-
121.Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes // Annals of Internal Medicine, 173 (2020), 7; 595-595 doi:10.7326/l20-1055 (međunarodna recenzija, pismo uredniku, znanstveni)
-
122.Dietary Supplement Use and Patient Outcomes in High- Risk Early-Stage Breast Cancer // Journal of clinical oncology, 38 (2020), 18; 2110-2110 doi:10.1200/JCO.20.00091 (međunarodna recenzija, pismo, znanstveni)
-
123.Patients with higher body mass index treated with direct / novel oral anticoagulants (DOAC / NOAC) for atrial fibrillation experience worse clinical outcomes // International Journal of Cardiology, 301 (2020), 90-95 doi:10.1016/j.ijcard.2019.10.035 (međunarodna recenzija, članak, ostalo)
-
124.Patients with atrial fibrillation and mid-range ejection fraction differ in anticoagulation pattern, thrombotic and mortality risk independently of CHA2DS2-VASC score // Heart and Vessels, 30 (2020), 32248252, 4 doi:10.1007/s00380-020-01603-2 (međunarodna recenzija, članak, znanstveni)
-
125.Prolonged methylprednisolone premedication prior to obinutuzumab in patients with chronic lymphocytic leukemia // Leukemia & lymphoma, 61 (2020), 4; 934-939 doi:10.1080/10428194.2019.1702182 (međunarodna recenzija, članak, znanstveni)
